Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Sublingual tizanidine 12 mg
(D08611)		[1] Tizanidine[1] Tizanidine (D08611) 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 13 💬
2Tizanidine
(D08611)		[1] Tizanidine[1] Tizanidine (D08611) 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 13 💬
3Tizanidine (sublingual or oral)
(D08611)		[1] Tizanidine[1] Tizanidine (D08611) 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 13 💬
4Tizanidine hydrochloride capsule
(D08611)		[1] Tizanidine[1] Tizanidine (D08611) 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 13 💬